Insider trading

Period: 120 months Stock: CRMD Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

17 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

17 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

17 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

17 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
17 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
17 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

17 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Sep 2025
Hurlburt Elizabeth Chief Operating Officer
Sold at will
$537.86K 41,121 at 13.08
18.9%
Not planned
9 Sep 2025
Zelnick Kaufman Beth Chief Legal Officer
Sold at will 2×
$670.26K 50,000 at 13.41
21.7%
Not planned
9 Sep 2025
Hurlburt Elizabeth Chief Operating Officer
Sold at will
$173.95K 12,876 at 13.51
6.8%
Not planned
14 Nov 2024
Sold at will
$1.57M 140,027 at 11.18
75.5%
Sold half or more
31 Oct 2024
Mistry Erin EVP, Chief Commercial Officer
Bought
$14.98K 1,500 at 9.99
3.0%
Largest buy in 3 yrs
17 Nov 2023
Mistry Erin Chief Commercial Officer
Bought
$4.00K 1,000 at 4.00
25.6%
First buy on file
21 May 2021
Hurlburt Elizabeth EVP, Head of Clinical Ops
Sold, plan not stated
$55.39K 8,000 at 6.92
100%
Sold half or more
14 Aug 2020
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations
Bought 3×
$116.11K 27,500 at 4.22
39.6%
First buy on file
13 Aug 2020
Mounts Phoebe General Counsel
Bought
$10.18K 2,525 at 4.03
54.0%
First buy on file
18 Mar 2020
Mounts Phoebe General Counsel
Bought
$9.91K 3,250 at 3.05
228%
First buy on file
30 Dec 2019
Mounts Phoebe General Counsel
Bought
$10.04K 1,425 at 7.04
opened
First buy on file
26 Mar 2019
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations
Bought
$38.65K 5,000 at 7.73
7.8%
First buy on file
25 Mar 2019
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations
Bought
$25.35K 15,000 at 1.69
4.9%
First buy on file
29 Nov 2018
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations
Bought
$363.15K 250,000 at 1.45
643%
First buy on file
12 Dec 2017
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations
Bought
$10.00K 20,833 at 0.48
opened
First buy on file
7 Feb 2017
Pfaffle Antony Chief Scientific Officer
Sold, plan not stated
$20.00K 10,000 at 2.00
100%
Sold half or more
21 Oct 2016
Pfaffle Antony Chief Scientific Officer
Sold, plan not stated
$44.60K 20,000 at 2.23
100%
Sold half or more
Showing 1–17 of 17.